|
Market Closed -
Nasdaq
00:00:00 12/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 120.75 USD | +1.05% |
|
+9.77% | -30.62% |
| 11-02 | Mizuho Adjusts Price Target on Insmed to $158 From $154, Keeps Outperform Rating | MT |
| 10-29 | Insmed Q3 Net Loss Narrows; Revenue Rises | MT |
| Market Cap | 26.49B 23.88B 22.06B 19.94B 37.73B 2,485B 38.66B 264B 105B 1,331B 99.42B 97.3B 4,235B | P/E 2026 * |
-73.7x | P/E 2027 * | 169x |
|---|---|---|---|---|---|
| Enterprise Value | 25.98B 23.41B 21.63B 19.55B 36.99B 2,436B 37.91B 259B 103B 1,305B 97.49B 95.41B 4,152B | EV / Sales 2026 * |
14x | EV / Sales 2027 * | 8.54x |
| Free-Float |
99.49% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| INSM | Delayed | |
CBOE
| INSM | Real-time | |
|
Mexican S.E.
| INSM * | End-of-day quote | |
|
Berne S.E.
| IM8N | End-of-day quote | |
|
Börse Stuttgart
| IM8N | Delayed | |
|
Tradegate
| IM8N | Real-time | |
|
Deutsche Boerse AG
| IM8N | Delayed | |
|
Boerse Muenchen
| IM8N | Real-time | |
|
Borsa Italiana
| 1INSM | End-of-day quote | |
|
Xetra
| IM8N | Delayed |
Last Transcript: Insmed Incorporated
| 1 day | +1.05% | ||
| 1 week | +9.77% | ||
| Current month | +7.26% | ||
| 1 month | +20.03% | ||
| 3 months | -8.92% | ||
| 6 months | +16.23% | ||
| Current year | -30.62% |
| 1 week | 107.29 |  | 120.88 |
| 1 month | 92.62 | | 120.88 |
| Current year | 90.39 | | 186.19 |
| 1 year | 90.39 | | 212.75 |
| 3 years | 21.92 | | 212.75 |
| 5 years | 16.04 | | 212.75 |
| 10 years | 11.31 | | 212.75 |
| Manager | Title | Age | Since |
|---|---|---|---|
Will Lewis
CEO | Chief Executive Officer | 57 | 10/09/2012 |
Martina Flammer
CTO | Chief Tech/Sci/R&D Officer | 62 | 19/12/2019 |
Roger Adsett
COO | Chief Operating Officer | 57 | 14/11/2019 |
| Director | Title | Age | Since |
|---|---|---|---|
Melvin Sharoky
CHM | Chairman | 75 | 16/06/2009 |
Will Lewis
CHM | Chairman | 57 | 08/11/2018 |
David Brennan
BRD | Director/Board Member | 72 | 29/05/2014 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/19/26 A | Free | Director | 6,139 | 0.0028% | ||
| 10/19/26 A | Free | Director | 6,139 | 0.0028% | ||
| 9/9/26 A | Sell | Director | -25,000 | 0.0114% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.05% | +9.77% | -37.66% | +408.42% | 26.49B | |
| -1.06% | -0.07% | +60.76% | +68.61% | 67.53B | |
| +1.12% | +8.61% | +13.86% | +92.52% | 60.74B | |
| +0.38% | -0.71% | +20.38% | +98.93% | 55.66B | |
| -0.95% | +11.17% | +22.21% | +110.93% | 47.97B | |
| -0.23% | +4.07% | +25.63% | +40.08% | 45.24B | |
| -6.40% | -9.51% | +181.99% | +816.79% | 39.08B | |
| +1.97% | +3.50% | +25.78% | +50.98% | 35.34B | |
| -0.59% | -2.12% | +81.02% | +57.57% | 33.45B | |
| 0.00% | +0.41% | +46.52% | +0.16% | 25.57B | |
| Average | -0.46% | +1.64% | +44.05% | +174.50% | 44B | |
| Weighted average by Cap. | -0.47% | +1.61% | +44.00% | +158.71% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.86B 1.68B 1.55B 1.4B 2.65B 175B 2.72B 18.58B 7.4B 93.5B 6.99B 6.84B 298B | 2.99B 2.7B 2.49B 2.25B 4.26B 281B 4.37B 29.86B 11.9B 150B 11.23B 10.99B 478B |
| Net income | -357M -322M -298M -269M -509M -33.52B -521M -3.57B -1.42B -17.95B -1.34B -1.31B -57.12B | 167M 151M 139M 126M 238M 15.7B 244M 1.67B 666M 8.41B 628M 615M 26.76B |
| Net Debt | -514M -464M -428M -387M -733M -48.25B -751M -5.13B -2.05B -25.84B -1.93B -1.89B -82.24B | -949M -855M -790M -714M -1.35B -89.01B -1.38B -9.47B -3.77B -47.67B -3.56B -3.49B -152B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 11/11/26 | $120.75 | +1.05% | 1,488,927 |
| 10/11/26 | $119.49 | +2.92% | 3,346,741 |
| 09/11/26 | $116.10 | +1.48% | 2,668,854 |
| 06/11/26 | $114.41 | +5.19% | 3,379,993 |
| 05/11/26 | $108.76 | -1.13% | 2,616,308 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- INSM Stock
Select your edition
All financial news and data tailored to specific country editions
